Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology

Acquisition will bring two differentiated commercialized immunology medicines to Biogen with EMPAVELI® FDA-approved in three indications, ...

Castle Biosciences, Inc. (CSTL) Discusses Clinical Utility and Evidence Supporting DecisionDx Melanoma Test and DECIDE Study Transcript

Discusses Clinical Utility and Evidence Supporting DecisionDx Melanoma Test and DECIDE Study March 23, 2026 4:30 ...
Wired

Palantir Demos Show How the Military Could Use AI Chatbots to Generate War Plans

An ongoing and heated dispute between the Pentagon and Anthropic is raising new questions about how the startup’s technology is actually used inside the US military. In late February, Anthropic ...
The Guardian

US man pleads guilty to defrauding music streamers out of millions using AI

Michael Smith, 52, charged after flooding platforms with thousands of AI songs and boosting them with bots Sign up for the Breaking News US email to get newsletter alerts in your inbox A North ...

Keller Group Plc - Annual Financial Report

Annual Financial Report. PR Newswire. LONDON, United Kingdom, March 24. 24 March 2026 . Keller Group plc . Annual Report and Accounts for the year ended 31 Dece ...
Seeking Alpha

Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates

ARLINGTON, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ: KALA) announces that it is ready to ship its first commercial AI product in approximately 14 days, transforming the Company ...